• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM FOLATE (FOL); FOLATE ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM FOLATE (FOL); FOLATE ASSAY Back to Search Results
Model Number N/A
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/07/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A united states (us) customer contacted a siemens customer care center (ccc) to report an elevated atellica im folate (fol) result that was considered discordant with the repeat result.The customer processed the serum sample using the folate rbc assay instead of the folate serum assay on the atellica im 1300 analyzer.The quality controls (qc) were in range at the time of the event.A siemens technical application specialist (tas) went to the customer's site.During the visit, the tas assisted the customer in deactivating fol (fol rbc) assay and adding the fol serum assay.The reagents were calibrated, and qc was run successfully.The sample was repeated, and the repeat result was reported to the physician(s), as the correct result.The interpretation of results section of the atellica im folate (fol) instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens healthcare diagnostics is investigating.
 
Event or Problem Description
The customer obtained an elevated atellica im folate (fol) result that was considered discordant with the repeat result.The initial result was reported to the physician(s) and was not questioned.There are no known reports of patient intervention or adverse health consequences due to the discordant folate result.
 
Additional Manufacturer Narrative
Mdr 1219913-2022-00371 was filed on oct 31, 2022 reporting an elevated result compared to repeat testing.A united states (us) customer contacted a siemens customer care center (ccc) to report an elevated atellica im folate (fol) result that was considered discordant with the repeat result.Additional information: jan 09, 2023.Siemens reviewed the information and determined that the elevated result is not attributable to the use of the incorrect fol calibration for serum samples because internal testing shows that use of the incorrect calibration yields lower values rather than higher values.Contributing factors such as pre-analytical factors and/or a sample handling/ stability issue cannot be ruled out.Internal siemens investigation indicates that the instrument and reagents were performing acceptably.The customer is operational.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM FOLATE (FOL)
Common Device Name
FOLATE ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key15699338
Report Number1219913-2022-00371
Device Sequence Number8246027
Product Code CGN
UDI-Device Identifier00630414598963
UDI-Public00630414598963
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K172201
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/20/2023
Device Model NumberN/A
Device Catalogue Number10995572
Device Lot Number337
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/07/2022
Supplement Date Received by Manufacturer01/09/2023
Initial Report FDA Received Date10/31/2022
Supplement Report FDA Received Date01/23/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/20/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-